Does ENZALUTAMIDE Cause Urinary tract infection? 660 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 660 reports of Urinary tract infection have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.3% of all adverse event reports for ENZALUTAMIDE.
660
Reports of Urinary tract infection with ENZALUTAMIDE
1.3%
of all ENZALUTAMIDE reports
123
Deaths
423
Hospitalizations
How Dangerous Is Urinary tract infection From ENZALUTAMIDE?
Of the 660 reports, 123 (18.6%) resulted in death, 423 (64.1%) required hospitalization, and 10 (1.5%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 660 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which ENZALUTAMIDE Alternatives Have Lower Urinary tract infection Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE